GLSI CIK: 1799788

Greenwich LifeSciences, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−4.29
FY22:
−6.20
FY23:
−6.48
FY24:
−7.27
FY25:
−9.91
Change from FY21 to FY25
millions USD
FY21:
2.84
FY22:
−7.54
FY23:
–
FY24:
4.37
FY25:
12.0
millions USD
FY21:
−1.46
FY22:
−13.7
FY23:
−6.48
FY24:
−2.90
FY25:
2.09

All amounts in millions USD Data source:SEC EDGAR